J
John G.F. Cleland
Researcher at National Institutes of Health
Publications - 1276
Citations - 125527
John G.F. Cleland is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Heart failure & Ejection fraction. The author has an hindex of 137, co-authored 1172 publications receiving 110227 citations. Previous affiliations of John G.F. Cleland include Northwestern University & Imperial College London.
Papers
More filters
Journal ArticleDOI
Effect of captopril, an angiotensin-converting enzyme inhibitor, in patients with angina pectoris and heart failure.
TL;DR: Captopril does not appear to be clinically useful in alleviating angina pectoris in patients with heart failure, and this effect may be related to a decrease in coronary perfusion pressure.
Journal ArticleDOI
Waist-to-hip ratio and mortality in heart failure.
Koen W. Streng,Adriaan A. Voors,Hans L. Hillege,Stefan D. Anker,John G.F. Cleland,Kenneth Dickstein,Kenneth Dickstein,Gerasimos Filippatos,Marco Metra,Leong L. Ng,Piotr Ponikowski,Nilesh J. Samani,Dirk J. van Veldhuisen,Aeilko H. Zwinderman,Faiez Zannad,Kevin Damman,Peter van der Meer,Chim C. Lang +17 more
TL;DR: The association between abdominal fat, measured via waist‐to‐hip ratio (WHR), BMI and all‐cause mortality in patients with HF is analysed.
Journal ArticleDOI
Recurrent infarction causes the most deaths following myocardial infarction with left ventricular dysfunction
TL;DR: In patients with evidence of major cardiac dysfunction after MI, recurrent MI found at autopsy is common and has often not been clinically detected.
Journal ArticleDOI
Adherence and perception of medication in patients with chronic heart failure during a five-year randomised trial.
Inger Ekman,Gull Andersson,Kurt Boman,Andrew Charlesworth,John G.F. Cleland,Philip A. Poole-Wilson,Karl Swedberg +6 more
TL;DR: Belief in medication may be related to how the patient experiences the medication's impact on functional ability, symptoms and well-being and early identification of patients' beliefs about medication seem to be an important factor in counselling and information to patients with CHF.
Journal ArticleDOI
Short‐term opioids for breathlessness in stable chronic heart failure: a randomized controlled trial
Stephen G Oxberry,David J. Torgerson,J Martin Bland,Andrew L. Clark,John G.F. Cleland,Miriam J. Johnson +5 more
TL;DR: To assess the effect of oral opioids vs. placebo on breathlessness in patients with chronic heart failure (CHF), a large number of patients are treated with either oral opioids or a placebo.